Adesso, S., Ruocco, M., Rapa, S. F., Piaz, F. D., Raffaele Di Iorio, B., Popolo, A., et al. (2019). Effect of indoxyl sulfate on the repair and intactness of intestinal epithelial cells: Role of reactive oxygen species’ release. International Journal of Molecular Sciences, 20, 9.

Article  Google Scholar 

Al-Chalabi, A., Jones, A., Troakes, C., King, A., Al-Sarraj, S., & van den Berg, L. H. (2012). The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathologica, 124, 339–352.

Article  CAS  PubMed  Google Scholar 

Ansari, U., Alam, M., Nadora, D., Muttalib, Z., Chen, V., Taguinod, I., FitzPatrick, M., Wen, J., Ansari, Z., & Lui, F. (2024). Assessing the efficacy of amyotrophic lateral sclerosis drugs in slowing disease progression: A literature review. AIMS Neuroscience, 11, 166–177. https://doi.org/10.3934/Neuroscience.2024.2.166

Article  PubMed  PubMed Central  Google Scholar 

Arotcarena, M. L., Dovero, S., Prigent, A., et al. (2020). Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates. Brain, 143, 1462–1475.

Article  PubMed  Google Scholar 

Ayala, V., Fontdevila, L., Rico-Rios, S., Povedano, M., Andrés-Benito, P., Torres, P., Serrano, J. C. E., Pamplona, R., & Portero-Otin, M. (2025). Microbial influences on amyotrophic lateral sclerosis: The gut–brain axis and therapeutic potential of microbiota modulation. Sclerosis, 3, 8.

Article  Google Scholar 

Baird, L., & Yamamoto, M. (2020). The molecular mechanisms regulating the KEAP1-NRF2 pathway. Molecular and Cellular Biology, 40, e00099.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bedlack, R., Li, X., Evangelista, B. A., Panzetta, M. E., Kwan, J., Gittings, L. M., & Sattler, R. (2024). The scientific and therapeutic rationale for off-label treatments in amyotrophic lateral sclerosis. Annals of Neurology, 97, 15–27.

Article  PubMed  PubMed Central  Google Scholar 

Beers, R., Zhao, W., Wang, J., et al. (2017). ALS patients’ regulatory T lymphocytes are dysfunctional and correlate with disease progression rate and severity. JCI Insight, 2, 5.

Article  Google Scholar 

Béland, L. C., Markovinovic, A., Jakovac, H., De Marchi, F., Bilic, E., Mazzini, L., Kriz, J., & Munitic, I. (2020). Immunity in amyotrophic lateral sclerosis: Blurred lines between excessive inflammation and inefficient immune responses. Brain Communications, 2, fcaa124.

Article  PubMed  PubMed Central  Google Scholar 

Benoit, E., & Escande, D. (1991). Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre. Pflugers Archiv, 419, 603–609.

Article  CAS  PubMed  Google Scholar 

Bilsland, L. G., Sahai, E., Kelly, G., Golding, M., Greensmith, L., & Schiavo, G. (2010). Deficits in axonal transport precede ALS symptoms in vivo. Proceedings of the National Academy of Sciences USA, 107, 20523–20528.

Article  CAS  Google Scholar 

Blacher, E., Bashiardes, S., Shapiro, H., Rothschild, D., Mor, U., Dori-Bachash, M., et al. (2019a). Potential roles of gut microbiome and metabolites in modulating ALS pathogenesis. Nature Communications, 10, 1–10. https://doi.org/10.1038/s41467-019-08453-9

Article  Google Scholar 

Blacher, E., Bashiardes, S., Shapiro, H., Rothschild, D., Mor, U., Dori-Bachash, M., et al. (2019b). Potential roles of gut microbiome and metabolites in modulating ALS progression. Nature Communications, 10, 5825.

Google Scholar 

Blacher, E., Bashiardes, S., Shapiro, H., Rothschild, D., Mor, U., Dori-Bachash, M., Zvibel, I., Elinav, E., Segal, E., Halpern, Z., Amariglio, N., Ben-Haim, S., & Koren, O. (2017). The gut microbiome in neurodegenerative disorders. Nature Reviews Neurology, 13, 359–371. https://doi.org/10.1038/nrneurol.2017.44

Article  Google Scholar 

Blasco, H., et al. (2018). Gut microbiota and amyotrophic lateral sclerosis: A potential mechanism. Frontiers in Cellular Neuroscience, 12, 460.

Google Scholar 

Blokhuis, A. M., Groen, E. J., Koppers, M., van den Berg, L. H., & Pasterkamp, R. J. (2013). Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathologica, 125, 777–794.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boddy, S. L., Giovannelli, I., Sassani, M., Cooper-Knock, J., Snyder, M. P., Segal, E., Elinav, E., Barker, L. A., Shaw, P. J., & McDermott, C. J. (2021). The gut microbiome: A key player in the complexity of amyotrophic lateral sclerosis (ALS). BMC Medicine, 19, 1–14.

Article  Google Scholar 

Borbolis, F., Mytilinaiou, E., & Palikaras, K. (2023). The crosstalk between microbiome and mitochondrial homeostasis in neurodegeneration. Cells, 12(3), 429.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boros, B. D., Schoch, K. M., Kreple, C. J., & Miller, T. M. (2022). Antisense oligonucleotides for the study and treatment of ALS. Neurotherapeutics, 19, 1145–1158.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brenner, D., et al. (2018). Hot-spot KIF5A mutations cause familial ALS. Brain, 141, 688–697.

Article  PubMed  PubMed Central  Google Scholar 

Brenner, D., et al. (2023a). Gut microbiota and amyotrophic lateral sclerosis: A role for neuroinflammation. Cells, 12, 256. https://doi.org/10.3390/cells12010256

Article  Google Scholar 

Brenner, D., et al. (2023b). Gut microbiota and amyotrophic lateral sclerosis: A role for neuroinflammation. Cells, 12(1), 256.

Google Scholar 

Burberry, A., Wells, M. F., Limone, F., Couto, A., Smith, K. S., Keaney, J., et al. (2020). C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature, 582, 89–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burk, K., & Pasterkamp, R. J. (2019). Disrupted neuronal trafficking in amyotrophic lateral sclerosis. Acta Neuropathologica, 137, 859–877.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Butti, Z., & Patten, S. A. (2019a). RNA dysregulation in amyotrophic lateral sclerosis. Frontiers in Genetics, 9, 712. https://doi.org/10.3389/fgene.2018.00712

Article  CAS  PubMed  PubMed Central  Google Scholar 

Butti, Z., & Patten, S. A. (2019b). RNA dysregulation in amyotrophic lateral sclerosis. Frontiers in Genetics, 9, 712.

Article  PubMed  PubMed Central  Google Scholar 

Carriedo, S. G., Sensi, S. L., Yin, H. Z., & Weiss, J. H. (2000). AMPA exposures induce mitochondrial Ca2+ overload and ROS generation in spinal motor neurons in vitro. Journal of Neuroscience, 20, 240–250.

Article  CAS  PubMed  Google Scholar 

Casani-Cubel, J., Benlloch, M., Sanchis-Sanchis, C. E., Marin, R., Lajara-Romance, J. M., & de la Rubia Orti, J. E. (2021). The impact of microbiota on the pathogenesis of amyotrophic lateral sclerosis and the possible benefits of polyphenols. An overview. Metabolites, 11(2), 120.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cecerska-Heryć, E., Pękała, M., Serwin, N., et al. (2023). The use of stem cells as a potential treatment method for selected neurodegenerative diseases: Review. Cellular and Molecular Neurobiology, 43, 2643–2673. https://doi.org/10.1007/s10571-023-01234-5

Article  PubMed  PubMed Central  Google Scholar 

Chen, S., Cai, X., Lao, L., Wang, Y., Su, H., & Sun, H. (2024). Brain-gut-microbiota axis in amyotrophic lateral sclerosis: A historical overview and future directions. Aging & Disease, 15, 74–95. https://doi.org/10.14336/AD.2023.1231

Article  Google Scholar 

Ciranna, L. (2006). Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: Implications in physiological functions and in pathology. Current Neuropharmacology, 4, 101–114.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clarke, B. E., & Patani, R. (2020). The microglial component of amyotrophic lateral sclerosis. Brain, 143, 3526–3539.

Article  PubMed  PubMed Central  Google Scholar 

Coque, E., Salsac, C., Espinosa-Carrasco, G., Varga, B., Degauque, N., Cadoux, M., et al. (2019). Cytotoxic CD8+ T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons. Proceedings of the National Academy of Sciences USA, 116, 2312–2317. https://doi.org/10.1073/pnas.1815961116

Article  CAS